LEADER 00999nam0-22003251i-450-
001 990007126780403321
005 20021014
035   $a000712678
035   $aFED01000712678
035   $a(Aleph)000712678FED01
035   $a000712678
100   $a20021014d1934----km-y0itay50------ba
101 0 $aita
102   $aIT
105   $ay---n---001yy
200 1 $aCodici e leggi del Regno d'Italia$iCodice penale e codice di procedura penale (vigenti dal 1. luglio 1931)$f[a cura di] Luigi Franchi
210   $aMilano$cHoepli$d1934
215   $a352 p.$d24 cm
225 1 $aManuali Hoepli
517 1 $aCodice penale e codice di procedura penale (vigenti dal 1. luglio 1931)
676   $a345$v20$zita
702  1$aFranchi,$bLuigi
710 01$aItalia$0423419
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990007126780403321
952   $aBIBLIOTECA SOLAZZI XII 7$b64103$fFGBC
959   $aFGBC
996   $aCodici e leggi del Regno d'Italia$9371162
997   $aUNINA

LEADER 01466nam  2200385Ia 450 
001 9910698929103321
005 20090716152724.0
035   $a(CKB)5470000002398587
035   $a(OCoLC)426052269
035   $a(EXLCZ)995470000002398587
100   $a20090716d2005      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry and FDA staff$b[electronic resource] $eapplication user fees for combination products
210  1$a[Rockville, MD] :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of Combination Products,$d[2005]
215   $a15 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on July 17, 2009).
300   $a"April 2005".
517   $aGuidance for industry and FDA staff 
606   $aUser charges$xGovernment policy$zUnited States
606   $aDrug approval$xGovernment policy$zUnited States
606   $aChemotherapy, Combination
615  0$aUser charges$xGovernment policy
615  0$aDrug approval$xGovernment policy
615  0$aChemotherapy, Combination.
712 02$aUnited States.$bFood and Drug Administration.$bOffice of Combination Products.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698929103321
996   $aGuidance for industry and FDA staff$93451983
997   $aUNINA